{"count": 3, "results": [{"_id": "29484149", "pmid": 29484149, "pmcid": "PMC5824534", "title": "Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA)", "journal": "Mol Autism", "authors": ["Stivaros S", "Garg S", "Tziraki M", "Cai Y", "Thomas O", "Mellor J", "Morris AA", "Jim C", "Szumanska-Ryt K", "Parkes LM", "Haroon HA", "Montaldi D", "Webb N", "Keane J", "Castellanos FX", "Silva AJ", "Huson S", "Williams S", "Gareth Evans D", "Emsley R", "Green J", "SANTA Consortium"], "date": "2018-02-22T00:00:00Z", "doi": "10.1186/s13229-018-0190-z", "meta_date_publication": "2018", "meta_volume": "9", "meta_issue": "", "meta_pages": "12", "score": 50083.86, "text_hl": "Randomised controlled trial of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment for @DISEASE_Autistic_Disorder @DISEASE_MESH:D001321 @@@autism@@@ in young children with @<m>DISEASE_Neurofibromatosis_1</m> @DISEASE_MESH:D009456 @@@neurofibromatosis type 1@@@ (SANTA)", "citations": {"NLM": "Stivaros S, Garg S, Tziraki M, Cai Y, Thomas O, Mellor J, Morris AA, Jim C, Szumanska-Ryt K, Parkes LM, Haroon HA, Montaldi D, Webb N, Keane J, Castellanos FX, Silva AJ, Huson S, Williams S, Gareth Evans D, Emsley R, Green J, SANTA Consortium. Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA) Mol Autism. 2018;9():12. PMID: 29484149", "BibTeX": "@article{29484149, title={Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA)}, author={Stivaros S and Garg S and Tziraki M and Cai Y and Thomas O and Mellor J and Morris AA and Jim C and Szumanska-Ryt K and Parkes LM and Haroon HA and Montaldi D and Webb N and Keane J and Castellanos FX and Silva AJ and Huson S and Williams S and Gareth Evans D and Emsley R and Green J and SANTA Consortium}, journal={Mol Autism}, volume={9}, pages={12}}"}}, {"_id": "24090588", "pmid": 24090588, "title": "Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.", "journal": "Lancet Neurol", "authors": ["van der Vaart T", "Plasschaert E", "Rietman AB", "Renard M", "Oostenbrink R", "Vogels A", "de Wit MC", "Descheemaeker MJ", "Vergouwe Y", "Catsman-Berrevoets CE", "Legius E", "Elgersma Y", "Moll HA"], "date": "2013-11-01T00:00:00Z", "doi": "10.1016/S1474-4422(13)70227-8", "meta_date_publication": "2013 Nov", "meta_volume": "12", "meta_issue": "11", "meta_pages": "1076-83", "score": 50061.7, "text_hl": "The use of 20-40 mg @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ per day for cognitive enhancement in children with @<m>DISEASE_Neurofibromatosis_1</m> @DISEASE_MESH:D009456 @@@neurofibromatosis type 1@@@ is not recommended. ", "citations": {"NLM": "van der Vaart T, Plasschaert E, Rietman AB, Renard M, Oostenbrink R, Vogels A, de Wit MC, Descheemaeker MJ, Vergouwe Y, Catsman-Berrevoets CE, Legius E, Elgersma Y, Moll HA. Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial. Lancet Neurol. 2013 Nov;12(11):1076-83. PMID: 24090588", "BibTeX": "@article{24090588, title={Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.}, author={van der Vaart T and Plasschaert E and Rietman AB and Renard M and Oostenbrink R and Vogels A and de Wit MC and Descheemaeker MJ and Vergouwe Y and Catsman-Berrevoets CE and Legius E and Elgersma Y and Moll HA}, journal={Lancet Neurol}, volume={12}, number={11}, pages={1076-83}}"}}, {"_id": "26519538", "pmid": 26519538, "title": "Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.", "journal": "Neurology", "authors": ["van der Vaart T", "Rietman AB", "Plasschaert E", "Legius E", "Elgersma Y", "Moll HA", "NF1-SIMCODA Study Group"], "date": "2016-01-12T00:00:00Z", "doi": "10.1212/WNL.0000000000002118", "meta_date_publication": "2016 Jan 12", "meta_volume": "86", "meta_issue": "2", "meta_pages": "154-60", "score": 50057.426, "text_hl": "METHODS: Data were analyzed from the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ for @DISEASE_Cognition_Disorders @DISEASE_MESH:D003072 @@@cognitive deficits@@@ and @DISEASE_Mental_Disorders @DISEASE_MESH:D001523 @@@behavioral problems@@@ in @SPECIES_9606 @@@patients@@@ with @GENE_NF1 @GENE_4763 @@@neurofibromatosis type 1@@@ (@<m>DISEASE_Neurofibromatosis_1</m> @DISEASE_MESH:D009456 @@@NF1@@@-SIMCODA) trial, a randomized placebo-controlled trial of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ for @DISEASE_Cognition_Disorders @DISEASE_MESH:D003072 @@@cognitive deficits@@@ and @DISEASE_Mental_Disorders @DISEASE_MESH:D001523 @@@behavioral problems@@@ in children with @<m>DISEASE_Neurofibromatosis_1</m> @DISEASE_MESH:D009456 @@@NF1@@@. ", "citations": {"NLM": "van der Vaart T, Rietman AB, Plasschaert E, Legius E, Elgersma Y, Moll HA, NF1-SIMCODA Study Group. Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1. Neurology. 2016 Jan 12;86(2):154-60. PMID: 26519538", "BibTeX": "@article{26519538, title={Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.}, author={van der Vaart T and Rietman AB and Plasschaert E and Legius E and Elgersma Y and Moll HA and NF1-SIMCODA Study Group}, journal={Neurology}, volume={86}, number={2}, pages={154-60}}"}}]}